Experts say the debate between Trish Regan and Liu Xin will help a Communist Party-controlled television network raise its profile in America, where it has struggled to gain a foothold.
Author: AMY QIN
To Many Chinese, America Was Like ‘Heaven.’ Now They’re Not So Sure.
As the trade war rages, ambivalence in China about the United States has posed an unusual challenge for the Communist Party.
In China, a Podcast Inspired by ‘This American Life’ Gives Voice to the Real
Hundreds of thousands of listeners are drawn to the stories of ordinary people on “Gushi FM,” told with an authenticity that’s rare in China’s media landscape.
Knife Attack at Chinese Elementary School Leaves Two Children Dead
The attack occurred early on Wednesday in Hunan Province. The authorities said a suspect, a 31-year-old man, had been taken into custody.
Pritzker Prize Goes to Arata Isozaki, Designer for a Postwar World
The architect synthesizes Western and Japanese influences without ceding to one style.
Stop Asking Women About Childbearing Status, China Tells Employers
The Chinese government, which has struggled to keep women from leaving the labor force, is taking new steps to combat persistent workplace discrimination.
Dissident Artist Ai Weiwei Is Cut From Film; Producer Cites ‘Fear of China’
A segment directed by Mr. Ai, a vocal critic of the Chinese government, was dropped from “Berlin, I Love You,” under what producers described as pressure from investors and distributors.
Film Set in China’s Cultural Revolution Is Pulled From Berlin Festival
The withdrawal of the film by the noted Chinese director Zhang Yimou comes amid a broader crackdown on the discussion of sensitive subjects in China.
Turkey Urges China to End Mass Detention of Muslims
The rare rebuke of the Chinese crackdown by a majority-Muslim country came after reports that a prominent Uighur folk poet had died in detention.
China Investigates Reports of H.I.V.-Tainted Blood Plasma Treatment
Authorities in China have ordered an emergency recall of more than 12,000 units of a blood plasma product, potentially the latest scandal to undermine public trust in the nation’s health care system.